Having secured the funds for the initial phase of the deployment of the world’s first malaria vaccine, the World Health Organization (WHO) announced it will be rolled out in sub-Saharan Africa and immunization campaigns...
Neonatal mouse model provides a new platform for Zika virus research A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines...
Scientists at the UNC School of Medicine are working to develop a nanoparticle vaccine to protect against the four serotypes of dengue virus, which infects more than 350 million people across the globe each year...
The addition of adjuvants to vaccines to stimulate the immune system toward the antigen being injected is a common practice of vaccine delivery. However, trying to awaken the reservoir of dormant viruses in combination...
Vaccination generated robust and protective antigen-specific antibody and T cell immune responses in preclinical animal models. As the global spread of the Zika virus continues, efforts are underway to halt the...
How to protect yourself and those around you—especially infants—from this highly contagious disease Whooping cough, also known as pertussis, was close to eradication in the 1970s, thanks to the whooping cough vaccine...
Saint Louis University Center for Vaccine Development researchers have identified a potential new target for vaccines that activates a part of the immune system not previously known to be protective against Chagas...
History will be made this week, when the first participant in a large-scale HIV vaccine trial receives a shot of the vaccine, designed to prevent a strain of HIV prevalent in southern Africa. Although vaccines are not...
Umeå University is among the 25 leading research and public health organizations from Latin America, North America, Africa, Asia, and Europe gathered in Recife, Brazil, for the launch of ZikaPLAN (Zika Preparedness...
Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute (TSRI) have discovered one reason why success has so...